One‐step transvaginal three‐dimensional hysterosalpingo‐foam sonography (3D‐HyFoSy) confirmation test for Essure® follow‐up: a multicenter study

Zizolfi, Brunella; Lazzeri, Lucia; Franchini, Mario; Sardo, Attilio Di Spiezio; Nappi, Carmine; Piccione, Emilio; Exacoustòs, C.

doi:10.1002/uog.17398

Cited by 6 publications

(3 citation statements)

References 64 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…evaluating the agreement level between HyFoSy and HSG in evaluating tubal patency. Our result showed a moderate agreement level of 81% (Cohen's kappa coefficient level of 0.42), which was lower than previous studies by Zizolfi et al in Italy with 100% agreement[5] and by Dreyer et al in the Netherlands with 97.4% agreement[6]. This difference was likely due to different study population since the subjects in these two studies were women with Essure placement that occluded the proximal part of the Fallopian tubes.…”

contrasting

confidence: 84%

“…Ludwin et al described that HyFoSy has a sensitivity of 87% and specificity of 94% [3], which was higher than HSG that had a sensitivity of 63% and specificity of 89% [4]. Zizolfi et al in Italy performed a concordance study between HyFoSy and HSG that was performed on 50 women who had undergone hysteroscopic Essure microinsert placement and found a concordance rate of 100% [5].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Hysterosalpingo-Foam Sonography to Replace HSG in Evaluating Tubal Patency in Indonesian Subfertile Patients

Situmorang¹,

Tantry²,

Gunardi³

2020

OJOG

View full text Add to dashboard Cite

Aim: To evaluate whether hysterosalpingo-foam sonography (HyFoSy) can replace HSG as first-line evaluation for tubal patency in subfertile Indonesian patients by evaluating agreement level and comparing patients' subjective complaints. Methods: Twenty subfertile female patients at Cipto Mangunkusumo Central General Referral Hospital (RSCM) from January 2018 to January 2019 were recruited conveniently to undergo both HSG and subsequent two-dimensional transvaginal HyFoSy after a minimum interval of 48 hours. Data on tubal patency and side effects inflicted by each examination within 24 hours were collected. Results: There were 20 subjects enrolled in this study. In 2 subjects, stenosis of internal uterine ostium was identified on HyFoSy procedure. Out of 36 remaining tubes undergoing adequate tubal patency evaluation by HSG and HyFoSy, agreement was seen in 81% cases (kappa value 0.42). The discordant tubal evaluation results in 7 of 36 tubes were associated with partial tubal obstruction, presence of co-existing gynaecological pathology, and tubal spasm. Less pain (p < 0.001) was experienced in HyFoSy as compared to HSG, with mean VAS of 1.8 ± 1.4 cm and 5.4 ± 2.4 cm, respectively. Seven of 20 patients experienced side effects due to HSG, such as abdominal cramp, spotting, backache, and bloating, in contrast to only one subject experiencing spotting due to HyFoSy. There was no hypersensitivity reaction observed in all subjects during HSG and HyFoSy procedure. Conclusions: HyFoSy has shown an excellent acceptance in Indonesian patients and could be a good alternative to replace HSG as a first line tubal patency examination.

show abstract

contrasting

confidence: 84%

Section: Introductionmentioning

confidence: 99%

Hysterosalpingo-Foam Sonography to Replace HSG in Evaluating Tubal Patency in Indonesian Subfertile Patients

Situmorang¹,

Tantry²,

Gunardi³

2020

OJOG

View full text Add to dashboard Cite

show abstract

“…Table 1 lists the characteristics of the studies 15,16,26–29 . A total of 622 fallopian tubes were used to estimate the accuracy of HyFoSy in diagnosing tubal occlusion.…”

Section: Synthesis Of the Resultsmentioning

confidence: 99%

Hysterosalpingo‐Foam Sonography for the Diagnosis of Tubal Occlusion

Melcer¹,

Sharon²,

Nimrodi³

et al. 2020

J of Ultrasound Medicine

View full text Add to dashboard Cite

This systematic review and meta‐analysis evaluated the diagnostic accuracy of hysterosalpingo‐foam sonography in suspected cases of tubal occlusion. The combined sensitivity and specificity estimates were 0.99 (95% confidence interval [CI], 0.89–0.99) and 0.91 (95% CI, 0.53–0.98), respectively, with positive and negative likelihood ratios of 11.5 (95% CI, 1.5–87.5) and 0.006 (95% CI, 0.0003–0.12), respectively. The diagnostic odds ratio was 1931.008 (95% CI, 69.7–53,460.8). These findings confirm hysterosalpingo‐foam sonography as a highly accurate test for the diagnosis of tubal occlusion and show that it is on a par with standard tests.

show abstract

Follicular Fluid Metabolomics: Tool for Predicting IVF Outcomes of Different Infertility Causes

Zhang,

He,

et al. 2024

Reprod. Sci.

View full text Add to dashboard Cite

Infertility affects approximately 15% of couples at child-bearing ages and assisted reproductive technologies (ART), especially in vitro fertilization and embryo transfer (IVF-ET), provided infertile patients with an effective solution. The current paradox is that multiple embryo transfer that may leads to severe obstetric and perinatal complications seems to be the most valid measure to secure high success rate in the majority of clinic centers. Therefore, to avoid multiple transfer of embryos, it is urgent to explore biomarkers for IVF prognosis to select high-quality oocytes and embryos. Follicular fluid (FF), a typical biofluid constituted of the plasma effusion and granulosa-cell secretion, provides essential intracellular substances for oocytes maturation and its variation in composition reflects oocyte developmental competence and embryo viability. With the advances in metabolomics methodology, metabolomics, as an accurate and sensitive analyzing method, has been utilized to explore predictors in FF for ART success. Although FF metabolomics has provided a great possibility for screening markers with diagnostic and predictive value, its effectiveness is still doubted by some researchers. This may be resulted from the ignorance of the impact of sterility causes on the FF metabolomic profiles and thus its predictive ability might not be rightly illustrated. Therefore, in this review, we categorically demonstrate the study of FF metabolomics according to specific infertility causes, expecting to reveal the predicting value of metabolomics for IVF outcomes.

show abstract

One‐step transvaginal three‐dimensional hysterosalpingo‐foam sonography (3D‐HyFoSy) confirmation test for Essure® follow‐up: a multicenter study

Abstract: Objective

Cited by 6 publications

References 64 publications

Hysterosalpingo-Foam Sonography to Replace HSG in Evaluating Tubal Patency in Indonesian Subfertile Patients

Hysterosalpingo-Foam Sonography to Replace HSG in Evaluating Tubal Patency in Indonesian Subfertile Patients

Hysterosalpingo‐Foam Sonography for the Diagnosis of Tubal Occlusion

Follicular Fluid Metabolomics: Tool for Predicting IVF Outcomes of Different Infertility Causes

Contact Info

Product

Resources

About